Skip to main content
. 2015 Sep 17;10(9):e0138248. doi: 10.1371/journal.pone.0138248

Fig 1. Multiple myeloma patients with del(8)(p21) have poor TTP and OS.

Fig 1

Time to progression (TTP) of (A) all patients, (B) HDT patients, (C) non-HDT patients after diagnosis (months). Overall survival (OS) of (D) all patients, (E) HDT patients, (F) non-HDT patients after diagnosis (months). Patients with del(8)(p21) (n = 24). Patients without del(8)(p21) (n = 64). HDT patients with del(8)(p21) (n = 14). HDT patients without del(8)(p21) (n = 41). Non-HDT patients with del(8)(p21) (n = 10). Non-HDT patients without del(8)(p21) (n = 23). Log-rank (Mantel-cox) test performed using Graphpad Prism software.